Clinical Trial Update: Add-on Cangrelor in STEMI-triggered Cardiac Arrest [Phase 4]

View source ↗

Summary

Phase 4 trial exploring add-on cangrelor in patients with STEMI-triggered cardiac arrest after successful resuscitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiopulmonary Arrest
• Coronary Syndrome

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: Medical University of Vienna | Conditions: Cardiopulmonary Arrest With Successful Resuscitation, ACS - Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN